pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
CRO/CDMO · news · pharmadog
← back to CRO/CDMO
News · CRO/CDMO
155
stories
2d
As part of sales reorganization, Novo will cut 215 employees at US HQ
biospace
3d
9 biotechs will cut at least half their California workforces
biospace
4d
Crown Biosciences stays put as $204M Adicon deal falls through
fiercebiotech
4d
White House yanks Overton nomination hours before committee vote
biospace
6d
Their loss, our gain? Canada makes its case to Europe amid U.S. instability
biospace
6d
BeOne, Hengrui top list of China’s most powerful drugmakers
stat
9d
PharmaLogic buys Lantheus plant to build transatlantic radiopharmaceutical CDMO
biospace
9d
Clene Nanomedicine uses CRO Veristat’s biostatistics platform for FDA submission
fiercebiotech
9d
Charles River pays $470M for 2 Frontage bioanalysis labs in Pennsylvania
fiercebiotech
10d
Merck KGaA's writedown over Lonza deal; PharmaLogic buys Lantheus' CDMO business
endpoints
10d
Chutes & Ladders—Bristol Myers' research chief out amid R&D reorganization
fiercebiotech
10d
2026 Q3 Job Market Report: Job opportunities, layoffs show YOY improvement
biospace
10d
Biopharma layoffs rise YOY in October but sharply trend down for 2026
biospace
11d
Valo and Montai become one as the Flagship AI-based biotechs tie the knot
fiercebiotech
12d
Start Center for Cancer Research opens first early-phase clinical trial site in Italy
fiercebiotech
13d
US government removes WuXi AppTec from Chinese military list
endpoints
13d
Rivia launches AI-powered clinical trial data review module, with Scancell as early adopter
fiercebiotech
13d
Before GMP: Six manufacturing considerations gene therapy sponsors should address earlier
biospace
16d
Forge’s Piteri-Molina on AI, Ohio and what’s next for gene therapy manufacturing
biospace
18d
Charles River teams up with Ipsen to use virtual control groups in toxicology studies
fiercebiotech
18d
nPhase rakes in $30M to expand AI-native clinical data platform
fiercebiotech
19d
Lonza agrees to buy 5 Merck KGaA facilities to accelerate US expansion
biospace
19d
STAT+: Pharmalittle: We’re reading about a generic HIV prevention shot, Lonza buying U.S. facilities, and more
stat
19d
Updated: Merck KGaA is selling its CDMO business in the US to Lonza
endpoints
19d
Recon: Merck KGaA to exit CDMO business; Karyopharm to sell itself in bankruptcy
raps
20d
Can Saudi Arabia's burgeoning biotech hub withstand geopolitical pressures?
biospace
24d
The cost of waiting: What reaching clinical proof-of-concept sooner means for biotech cash burn
fiercebiotech
24d
Stability, speed and strategy: Inside Australia’s early‑stage edge
biospace
24d
Biopharma cuts at manufacturing plants expected to affect 4,000+
biospace
25d
Biotechs going to market alone must learn to go global
biospace
← prev
page 1 of 6
next →